Introduction
Lipocalins are a diverse class of secreted glycoproteins that have been widely studied. 24p3 is also known as SIP24 (Davis et al., 1991) , uterocalin (Liu et al., 1997) and NGAL (human form) (Kjeldsen et al., 1993; Kjeldsen et al., 2000) . Lipocalins function in a variety of processes including nutrient transport (Flower et al., 1991) , binding of ferric iron structures (Goetz et al., 2002) and immune homeostasis (Devireddy et al., 2001) . Members of the lipocalin family have sequence conservation. Sequence similarity between family members (for example mouse and human) involves conserved cysteines and three motifs involved in target cell recognition (Kjeldsen et al., 2000) . Devireddy et al. (2001) detected increased 24p3 gene expression following IL-3 withdrawal in mouse FL5.12 cells. They further showed that mouse 24p3 induces apoptosis in normal blood cells including murine primary bone marrow, splenocytes, thymocytes, and human neutrophils and peripheral blood lymphocytes. Various mouse IL-3-dependent cell lines, such as 32D cells, are also susceptible to 24p3 apoptotic effects. Apoptosis induction by secreted 24p3 involves dephosphorylation of the proapoptotic protein Bad in the targeted cell (Devireddy et al., 2001) .
In this report, we found that several mouse hematopoietic cell lines transformed by the BCR-ABL oncogene persistently expressed 24p3 RNA and secreted the 24p3 protein into the culture medium. Conditioned medium (CM) obtained from BCR-ABL þ 32D cells induced apoptosis in mouse hematopoietic cells. However, BCR-ABL þ cells were resistant to the apoptotic effects of 24p3. BCR-ABL þ mouse 32D cells also induced a leukemic syndrome involving suppression of normal hematopoiesis in NOD/scid mice, which was strongly inhibited by reducing the expression of 24p3.
Results

Mouse hematopoietic cells expressing BCR-ABL persistently express 24p3 transcripts
Using RT-PCR, 24p3 RNA expression was found in several IL-3-dependent mouse hematopoietic cell lines transformed by BCR-ABL ( Figure 1a) . Importantly, 24p3 expression was independent of IL-3 ( Figure 1a ). Transformation of these cells with BCR-ABL abrogates the need for IL-3 for cell proliferation and survival (Daley et al., 1987) . BCR-ABLÀ counterparts of these cell lines require IL-3 for proliferation and survival, and produce only trace levels of 24p3 unless starved of IL-3 ( Figure 1a ). In contrast, BCR-ABL þ mouse hematopoietic cells constitutively produce transcripts of 24p3 independent of IL-3 ( Figure 1a ). Similar results were obtained with BaF3-BCR-ABL cell system (not shown). Importantly, transduction of BCR-ABL into primary mouse marrow cells also greatly stimulated expression of 24p3 transcripts (Figure 1b ).
24p3 expression in BCR-ABL þ cells requires the tyrosine kinase of Bcr-Abl
We examined the requirements for 24p3 expression in BCR-ABL þ 32D cells. We used the tetracycline (Tet) induction system to determine whether a reduction in BCR-ABL levels would reduce the level of 24p3 transcripts. Cells maintained in a high dose of Tet to suppress BCR-ABL expression had reduced levels of 24p3 transcripts relative to no Tet. Increased expression of BCR-ABL as measured by RT-PCR correlated with increased expression of 24p3 transcripts (Figure 2a) . Treatment of cells with imatinib mesylate (IM), a potent inhibitor of the Bcr-Abl tyrosine kinase (Druker, 2002) in the presence of IL-3 to prevent apoptosis induction, greatly reduced 24p3 transcripts (Figure 2b ). In the absence of IL-3, the level of transcripts showed a modest decrease but after 24 h in the presence of actual drug the level of 24p3 transcripts more than doubled (Figure 2c) , suggesting that the mechanism of the induction of 24p3 by Bcr-Abl is different from the mechanism of 24p3 induction utilized by IL-3 starvation of normal 32D cells (Figure 2c ). It is important to note that in the absence of IL-3 and in the presence of IM, these BCR-ABL þ cells immediately begin the process of stimulating 24p3 expression. Therefore, the reduction of 24p3 transcripts by IM at early times (e.g. l h), which is seen in Figure 2b , Marrow cells were infected with the MigR1 virus encoding either GFP or BCR-ABL(b3a2). 24p3 transcripts were measured by quantitative RT-PCR. Transcripts were normalized for loading using GAPDH transcripts. The results are average of three experiments Figure 2 The tyrosine kinase of Bcr-Abl is required for induction of 24p3 expression. (a) 24p3 expression is dependent on BCR-ABL expression. Tet-off BCR-ABL þ 32D cells were maintained in different doses of tetracycline for several days before analysis in the presence of IL-3 to maintain viability and cell proliferation at low levels of BCR-ABL. Total RNA was extracted and the levels of 24p3 and BCR-ABL RNA normalized by GAPDH RNA levels were examined by quantitative RT-PCR. (b) The tyrosine kinase activity of Bcr-Abl is required for expression of 24p3 transcripts. BCR-ABL þ 32D cells were treated with 10 mM imatinib for 1-24 h. The level of 24p3 RNA normalized by GAPDH RNA levels of treated and untreated cells was determined by quantitative RT-PCR. (c) Imatinib does not inhibit induction of 24p3 caused by withdrawal of IL-3 in BCR-ABL þ 32D cells. The experiment was performed as in panel b, except that the cells were washed free of IL-3 before treatment with imatinib Bcr-Abl-mediated suppression of normal hematopoiesis H Lin et al is not as vigorous when IL-3 is absent (Figure 2c) due to what appears to be two distinct mechanisms of 24p3 induction. Nevertheless, these results indicate that the tyrosine kinase activity of the Bcr-Abl oncoprotein is required for persistent induction of 24p3 expression.
BCR-ABL þ 32D cells are resistant to the apoptotic effects of CM from cells expressing 24p3
Since P210 BCR-ABL is known to activate Stat5, to increase expression of BCL-XL and BCL-2 proteins in a manner that is independent of the IL-3 receptor pathway, and inhibit the activation of Bad and that Bad and Bcl-XL antagonize each others effect on cell death (Salomoni et al., 2000) , we determined whether BCR-ABL expression in hematopoietic cells rendered them resistant to the apoptotic effects induced by 24p3. Indeed as expected, 32D cells were sensitive to apoptosis induction by CM from either IL-3-starved 32D cells or BCR-ABL þ 32D cells (Figure 3a) . In contrast, BCR-ABL þ 32D cells were resistant to the apoptotic effects of CM from either IL-3 starved 32D cells or BCR-ABL þ 32D cells ( Figure 3b ; Table 1 ). CM from BCR-ABL þ 32D cells also induced apoptosis in normal mouse bone marrow cells maintained in primary culture and 32D cells, but again BCR-ABL þ 32D cells were resistant to this treatment (Table 1) . Importantly, CM from COS1 cells transfected with the 24p3 cDNA also induced apoptosis in primary mouse marrow cells and 32D cells but not BCR-ABL þ 32D cells (Table 1) . Vector-transfected COS1 cells lacked this activity (not shown).
BCR-ABL þ 32D cells secrete 24p3
Western blotting detected the 24p3 protein in BCR-ABL þ 32D cells (P210 form in a mouse myeloid lineage) (Figure 4a and b) and in BCR-ABL þ FL5.12 cells (P210 form in a mouse lymphoid lineage) (not shown). In contrast, these cells when not expressing BCR-ABL had reduced levels of 24p3 protein unless deprived of IL-3 ( Figure 4c ). As expected, the 24p3 protein was also secreted into the CM of cells expressing BCR-ABL (Figure 4c ). To achieve efficient and rapid gene transduction in hematopoietic cells, we adopted a modified lentivitus gene transfer method (Ling et al., 2003) . BCR-ABL þ 32D cells were transduced with an antisense 24p3 sequence and enhanced green fluorescent protein (GFP) using infection with a bi-cistronic lentivirus (Ling et al., 2003) . The bi-cistronic lentivirus yields a viral mRNA that produces both antisense 24p3 and GFP. The EF1a promoter and the SIN modification (to eliminate the LTR promoter) were used to enhance expression in hematopoietic cells (Ling et al., 2003) . Cell sorting by flow cytometry was used to enrich the cultured cell population (more than 90%) for antisense 24p3/GFP expression. Lentivirus-infected cells expressed antisense 24p3 RNA, as determined by RT-PCR using a sense 24p3 primer and antisense GFP primer (not shown). Western blotting established that 24p3 protein levels were diminished relative to vector control BCR-ABL þ 32D cells in cells and in CM (Figure 4a and b). In separate experiments, lentivirus infection was used to transduce sense 24p3. Sense 24p3 expression increased the amount of 24p3 in BCR-ABL þ 32D cells ( Figure 4a ) and in CM (not shown). Two 24p3 siRNAs were separately transduced into BCR-ABL þ 32D cells using a lentivirus siRNA/GFP vector (Wiznerowicz and Trono, 2003) . Cell sorting produced cell populations that were more than 90% positive for GFP. Western blotting indicated that levels of 24p3 protein in these cells were reduced 40-60% ( Figure 4b ). CM from 24p3 antisense and 24p3 siRNA expressing cultures had significantly depressed levels of 24p3 protein ( Figure 4c ). As another indication that the antisense 24p3 produces low levels of 24p3, we transduced antisense 24p3 into FL5.12 cells and determined whether IL-3 starvation would cause less apoptosis than vector-transduced cells. Expression of antisense 24p3 in FL5.12 cells greatly reduced apoptosis induction (11%) compared to vector control (65%) when cells were maintained for 48 h in the absence of IL-3 (Supplementary Figure 1) . We determined whether the presence of 24p3 protein in CM correlated with its known property of inducing apoptosis. CM from 32D cells deprived of IL-3 induced apoptosis in 32D and FL512 cells, which were maintained in presence of 3 ng/ml IL-3 during treatment to maintain viability and to prevent induction of 24p3 ( Figure 5a ). As expected, CM from 32D cells maintained in IL-3 did not induce apoptosis. CM from BCR-ABL þ 32D cells expressing either the GFP gene (not shown) or sense 24p3 induced high levels of apoptosis in 32D target cells (Figure 5a ). In contrast, BCR-ABL þ 32D cells expressing either antisense 24p3 or siRNA for 24p3 had a greatly reduced level of apoptotic activity ( Figure 5a ).
We performed coculture experiments to determine whether BCR-ABL þ 32D cells would takeover the culture in a mixture of 32D cells and BCR-ABL þ 32D cells (Figure 5b ). In these experiments, we cocultured were cocultured with either 32D GFP þ cells or BCR-ABL þ 32D GFP cells in a 1 : 1 ratio in presence of 3 ng/ml recombinant IL-3. The cell cultures were diluted twofold with fresh CM with IL-3 every 2 days to maintain vigorous growth. The amount of viable GFPÀ 32D cells was analysed on day 0, 3, 7 and 13 by flow cytometry. (c) Antibody to 24p3 blocks the decrease in viability of IL-3-dependent primary bone marrow cells caused by CM from BCR-ABL þ 32D cells. CM from BCR-ABL þ 32D cells was supplemented with IL-3 (3 ng/ml) and added to BALB/c primary bone marrow cells. 1.5 mg of affinity-purified rabbit antibody to 24p3 or 2 mg of preimmune rabbit serum was added at the same time. Cell viability was determined by trypan blue staining after 48 h Bcr-Abl-mediated suppression of normal hematopoiesis H Lin et al 32D cells lacking GFP expression with an equal number of either 32D cells expressing GFP only or BCR-ABL þ 32D/GFP cells. Viable cells were determined by trypan blue staining. The number of viable 32D cells was unchanged when cocultured with 32D cells expressing GFP. In contrast, the number of 32D cells showed a dramatic reduction when cocultured with BCR-ABL þ 32D/GFP cells (Figure 5b ). It should be noted that the proliferation rate of BCR-ABL þ and BCR-ABLÀ 32D cells was essentially the same over the 13-day time period. Similar results were obtained with coculture of cells separated by a barrier that prevented mixing of cells (not shown).
24p3 antibody inhibits induction of cell death induced by 24p3
To provide evidence that 24p3 was required for the induction of apoptosis, we determined whether an affinity-purified antibody to 24p3 would inhibit the apoptotic-inducing activity of CM from BCR-ABL þ 32D cells. CM from BCR-ABL þ 32D cells, supplemented with IL-3 (3 ng/ml) to maintain viable cells, was added to BALB/c primary bone marrow cells. Marrow cells were tested for apoptosis after mixing with either 2 mg of protein from preimmune rabbit serum or 1.5 mg of protein from affinity-purified antibody to 24p3 compared to untreated controls (Figure 5c ). The mouse marrow target cells were assayed by trypan blue staining in triplicate after 48 h. The affinity-purified 24p3 antibody partially blocked the apoptotic activity (Figure 5c ), indicating that 24p3 was involved in apoptosis induction.
Reduction of 24p3 expression by BCR-ABL þ 32D cells extended survival and restored hematopoiesis in marrow and spleen of leukemic mice Injection of NOD/scid mice preconditioned by sublethal radiation with BCR-ABL þ mouse 32D cells caused a lethal leukemia syndrome (Figure 6a ) involving marrow and spleen tissue. The survival time of these mice after i.v. inoculation of the BCR-ABL þ cells varies between 15 and 25 days, and is dependent on the level of BCR-ABL expression. Pathology studies of spleen and marrow revealed that BCR-ABL þ 32D/GFP cells induced vigorous infiltration of GFP þ tumor cells into spleens and marrow. These leukemic tissues had only few regions of active normal hematopoiesis in NOD/scid mice that would normally produce erythrocytes, myeloid cells and megakaryocytes (Figure 6d and g) .
We examined the effects of reduced 24p3 expression in BCR-ABL þ 32D cells on the level of normal hematopoiesis in marrow and spleens of NOD/scid mice. A significant increase in the survival time was observed in mice injected with BCR-ABL þ 32D cells that expressed antisense 24p3 (Figure 6a ). Microscopic analysis revealed that leukemic spleen tissue and marrow from the antisense 24p3/GFP group of mice had a significantly larger amount of normal hematopoiesis (Figure 6c and f) compared to that of GFP vector control (Figure 6d and g ). Importantly, these tissues from antisense mice resembled those injected with 32D cells lacking BCR-ABL expression (Figure 6b and e) . Cause of death of mice injected with BCR-ABL þ 32D cells expressing antisense 24p3 appeared to be due to extensive liver involvement. In contrast, when 24p3 expression was maintained, marrow and spleen tissues were heavily infiltrated with leukemia cells and had very little normal hematopoiesis (Figure 6d and g ), suggesting that 24p3 secretion by leukemic cells is responsible for the observed reduction of normal hematopoiesis.
Since the leukemia cells are expressing GFP, we measured the engraftment of leukemic cells in marrow and spleen of leukemic mice. Antisense expression in BCR-ABL þ 32D cells reduced invasion of spleen by more than 35-fold (Figure 7a ) in leukemic mice between 16 and 18 days after injection. Similarly, invasion of bone marrow was reduced almost 20-fold by antisense expression. Spleens and marrow fluid from these mice were assessed for levels of 24p3 by Western blotting. Bone marrow fluid from mice injected with antisense 24p3-expressing BCR-ABL þ 32D cells contained essentially no 24p3 protein, whereas GFP-expressing cells contained relatively high levels of 24p3. Mice treated with radiation and not injected with leukemia cells also had no detectable amount of 24p3 (Figure 7b ).
Another measure of normal hematopoiesis is the blood platelet levels. We measured the level of platelets in blood from these leukemic mice. Mice injected with antisense 24p3 expressing BCR-ABL þ 32D cells had greatly increased blood platelets levels compared to GFP vector cells or cells expressing sense 24p3 (Figure 7c) . Similarly, leukemic C3H/HeJ mice injected with BCR-ABL þ 32D cells had severely depressed platelet levels but again injection of cells expressing antisense 24p3 dramatically increased the levels of platelets in peripheral blood (Figure 7c ). These findings support the microscopic pathological findings which indicate that mice injected with antisense 24p3-expressing BCR-ABL þ 32D cells have enhanced levels of normal hematopoiesis including megakaryocytes (Figure 6b-g ).
We also measured levels of normal hematopoietic cells in the marrow and spleen of NOD/scid mice during 16-18 days after injecting leukemia cells, at which time mice were sick from leukemia. In these experiments, GFPÀ cells were analysed by flow cytometry with cell surface markers for erythroid and myeloid lineages. The results showed a dramatic increase erythroid precursors in marrow and spleen of leukemic mice injected with BCR-ABL þ 32D cells expressing antisense 24p3 (Figure 8a and d) . The level of erythroid cells was similar to that in irradiated control mice. There was a simlar increase in myeloid lineage cells in marrow of antisense 24p3 mice, although not as great as erythroid lineage cells (Figure 8b ). Of interest, there was an increase of non-erythroid/myeloid lineage cells in leukemic mice injected with GFP-transduced BCR-ABL þ 32D cells compared to the antisense 24p3 mice or untreated control mice (Figure 8c and f) . These results indicate that reduced secretion of 24p3 by the BCR-ABL þ 32D cells induces a disease that has little involvement of the marrow and spleen, which are sites typically marked by substantial invasion with leukemic cells. Based on our cell death findings and coculture experiments in vitro, these results suggest that BCR-ABL þ 32D cells must induce cell death of normal 
Expression of antisense 24p3 does not affect the level of BCR-ABL expression and cell properties
It is important to determine whether expression of antisense 24p3 in BCR-ABL þ 32D cells effects their oncogenic properties. We assessed the level of the BcrAbl oncoprotein in GFP vector control cells and cells transduced with antisense 24p3, and two siRNAs for 24p3 knockdown. Western blotting established that the level of BCR-Abl protein expression was not affected after several months in cell culture (Supplementary Figure 2) . In addition, the phosphotyrosine content of Bcr-Abl was also not affected by reduction of 24p3 (not shown). Similarly, 24p3 antisense expression did not affect the proliferation rate and cellular morphology (not shown). This is consistent with our findings that 24p3 antisense expression in leukemia cells still induced disease in mice with only a modest increase in survival (Figure 6a ). These mice show heavy invasion of leukemia cells in the liver, which appeared to be the cause of death. Importantly, experiments in the C3H/ HeJ model showed that injection of BCR-ABL þ 32D cells expressing antisense 24p3 and 24p3 siRNA proliferated quite well in these mice, causing induction of solid tumors and ascites formation but like the NOD/ scid model, these mice had little involvement of marrow and spleen (see Table 2 ).
Homing of BCR-ABL þ 32D cells to various tissues of leukemic NOD/scid mice is not affected by antisense 24p3 expression
One question about 24p3 expression is whether it affects homing of BCR-ABL þ 32D cells in NOD/scid mice. To address this question, we searched for engraftment of BCR-ABL DNA in mice at 7 days after injection into mice. We used primers that detect the b3a2 junction of BCR-ABL. One round of PCR did not detect junction Protocol and processing methods are similar to that described in the legends of Figures 6 and 7 except the mice were not preconditioned by radiation. BCR-ABL+ 32D cells expressing either GFP or antisense 24p3 or siRNA #4 were used in this study, as in Figure 4 . N/A: not analysable.
N/D, not done
Bcr-Abl-mediated suppression of normal hematopoiesis H Lin et al preconditioning regimens (Matulonis et al., 1995) . Therefore, we wanted to determine whether the affects of antisense 24p3 expression in leukemia cells would produce the same effects as in the NOD/scid mouse. In these experiments, 10e6 BCR-ABL þ 32D cells were injected i.v. into 8-week old C3H/HeJ mice. Leukemia cells expressed either GFP or antisense 24p3 RNA or siRNA for 24p3. The GFP-expressing leukemia cells induced a vigorous leukemia involving marrow, spleen, blood and liver (Table 2) . Expression of antisense 24p3 in leukemia cells reduced the level of invasion in marrow and the spleen but not in the liver. Importantly, these mice developed a vigorous ascites tumor growth of GFP þ cells, which was not observed in the GFP vector-expressing leukemia cells. Similar results were observed in mice injected with BCR-ABL þ 32D cells expressing siRNA against 24p3 (Table 2) . Thus, the results of studies in two different mouse strains indicate that reduction of 24p3 expression levels strongly reduced the invasion of marrow and spleen but not liver, and in the case of the C3H mouse strain, reduction of 24p3 expression also caused a vigorous growth of leukemia cells in the form of an ascites.
Discussion
These findings indicate that the Bcr-Abl oncoprotein in addition to its oncogenic effects also induces the secretion of a lipocalin 2 (24p3) that causes apoptosis of marrow cells and BCR-ABLÀ mouse hematopoietic cells lines in cell culture (Figures 1-5 and Table 1 ). The induction of 24p3 expression by BCR-ABL requires the presence of the Bcr-Abl oncoprotein (Figure 2a ) and the tyrosine kinase activity of Bcr-Abl (Figure 2b) . Importantly, BCR-ABL þ cell lines are resistant to the apoptotic effects of 24p3 ( Figure 3 , Table 1 ). The resistance of BCR-ABL þ cells to 24p3 effects is consistent with the known mechanism of apoptosis induction by 24p3, which involves activation of the proapoptotic factor Bad. Bcr-Abl is known to prevent activation of Bad (Salomoni et al., 2000) and to stimulate expression of Bcl-XL and Bcl-2 (Salomoni et al., 2000) .
To determine the function of 24p3, we developed assays to measure apoptosis induction in target cells (Figures 3, 5 ) using CM from BCR-ABL þ cells. We also developed known genetic approaches to reduce expression of 24p3 by use of antisense and siRNAs directed against 24p3 RNA sequences. Expression of antisense 24p3 and two different siRNA sequences for 24p3 strongly reduced 24p3 protein expression in BCR-ABL þ 32D cells (Figure 4a and b) and also strongly reduced levels of 24p3 protein in the CM (Figure 4c ). CM from BCR-ABL þ 32D cells induced apoptosis in two different BCR-ABLÀ mouse hematopoietic cell lines (Figure 5a ). Reduction of 24p3 secretion by antisense/siRNA expression strongly reduced apoptotic activity of CM from BCR-ABL þ 32D cells (Figure 5a ). Coculture of 32D cells with BCR-ABL þ 32D cells allowed BCR-ABL þ cells to overtake the culture, despite the similar proliferation rates of these cells in culture separately (Figure 5b ).
Our studies demonstrated that an affinity-purified antibody against 24p3 inhibited the apoptotic activity of CM from BCR-ABL þ cells (Figure 5c ). Thus, these findings indicate that 24p3 functions as an apoptosisinducing factor in agreement with the findings of Devireddy et al. (2001) . However, we observed that 24p3 appears to exist in complexes, and thus whether 24p3 acts alone or in combination with other factors, remains to be determined.
Our coculture experiments and CM findings predict that BCR-ABL þ leukemia cells would overgrow spleen and marrow tissue sites by inducing cell death of normal hematopoietic cells, and thereby providing space for expansion of the invading leukemia cells. Our mouse model studies support this concept. In NOD/scid mice and C3H/HeJ mice, BCR-ABL þ 32D cells overgrow the marrow and spleen of leukemic mice. However, reduction of 24p3 expression by antisense or siRNA methods restores the level of hematopoiesis in marrow and spleen and elevates platelet levels in the blood (Figures 7 and 8) . Of interest, marrow fluid from these mice injected with BCR-ABL þ 32D cells expressing GFP contained 24p3 but marrow fluid from mice injected with antisense or untreated lacked 24p3 (Figure 7b ). In addition, NOD/scid mice injected with antisense 24p3-expressing BCR-ABL þ 32D cells had a small but significant increase in survival (Figure 6a ). This is surprising in view of the fact that the level of the Bcr-Abl oncoprotein is unaffected by the reduction of 24p3 expression (Supplementary Figure 2) .
One unlikely but possible explanation for the restoration of hematopoiesis in mice injected with 24p3 antisense-expressing BCR-ABL þ 32D cells is that these leukemia cells have lost the ability to proliferate in mouse tissues. This is not the case, as liver invasion readily takes place (Table 2) , solid tumors are formed and ascites formation also occurs (Table 2 ). Also, cell culture studies did not detect changes in the proliferation rate, morphology and levels of the BCR-ABL oncoprotein in either antisense 24p3 cultures or siRNAexpressing cultures compared to the GFP vector control (Supplementary Figure 2) . Thus, these findings support the concept that the reduction of 24p3 expression only interferes with invasion and growth of leukemia cells in marrow and the spleen.
The mechanisms of the effects that are caused by reduction of 24p3 in mice require further studies. Changes in homing of leukemia cells with reduced 24p3 expression does not appear to explain our results. Thus, our studies on homing 7 days after injection suggest that the leukemia cells home to many tissues and more importantly, the reduction of 24p3 did not affect the early engraftment of leukemia cells in various tissue sites (Supplementary Table 1 ). In addition, our preliminary studies suggest that normal marrow cells are undergoing apoptosis in leukemic tissues from mice where 24p3 expression is maintained since spleens of mice injected with BCR-ABL þ 32D cells had an increased level of apoptosis as measured by TUNEL staining (not shown). Technical difficulties make it difficult to monitor death of hematopoietic cells in spleen/marrow tissues extracted from sick mice due to rapid clearing of dead cells and because of the rapid overgrowth of BCR-ABL þ 32D cells that occurs at these sites. However, our CM studies and coculture studies suggest that the mechanism for efficient invasion and suppression of normal hematopoiesis in the marrow and spleen of leukemic mice expressing the full amount of 24p3 is due to induction of apoptosis in normal hematopoietic cells by the secreted 24p3 protein (Figures 3, 5, 7 and 8) .
These findings are likely to have important implications for chronic myeloid leukemia (CML). This blood cancer is believed to originate in a pluripotent stem cell by fusion of parts of the BCR and ABL genes through the formation of the Philadelphia chromosome. Suppression of normal hematopoiesis by a mechanism that does not interfere with the proliferation and survival of BCR-ABL þ cells would confer a significant cell growth and survival advantage for the leukemic clone in the competing normal marrow environment. Local suppression of normal hematopoiesis by apoptosis induction caused by 24p3 secreted by the leukemia cells would allow the leukemic clone to more readily survive, expand and invade in normal marrow and the spleen. These findings raise the possibility that secretion of an apoptosis-inducing molecule like 24p3 by the BCR-ABL þ human leukemia cells in CML would be important for the establishment of the leukemia clone at early stages of the leukemia process. Thus, as little as one pluripotent stem cell that has acquired BCR-ABL expression by forming the Philadelphia chromosome could survive and compete in the normally active marrow environment because of its ability to secrete a cell death factor and possibly other factors (Olofsson and Olsson, 1980a, b; Eaves et al., 1998; Skold et al., 1999) to which it is resistant.
In this regard, CML cells were shown to overproduce and secrete elastase, resulting in the reduction of growth factors such as G-CSF, thereby giving advantage to Ph þ hematopoiesis (EL-Ouriaghli et al., 2003) . Other negative factors are secreted by CML cells including transforming growth factor-b (TGF-b), tumor necrosis factor-a (TNF-a), macrophage inflammatory protein-1 (MIP1a) and monocyte chemoattractant protein-1 (MCP-1), and leukemia-associated inhibitor (LAI) (Olofsson and Olsson, 1980a, b; Eaves et al., 1998; Skold et al., 1999) . LAI inhibits normal but not leukemia granulopoiesis (Olofsson and Olsson, 1980a, b; Skold et al., 1999) . LAI was identified as neutrophil pro-proteinase 3, a member of the neutrophil serine protease family (Skold et al., 1999) . None of these factors were identified as apoptosis-inducing factors, and all were based on studies conducted in cell culture assays.
In a previous study of NOD/scid mice injected with clones of a CML cell line (K562 cells), we observed a leukemia syndrome involving not only an extramedullary leukemia but also a severe reduction of normal mouse hematopoiesis (termed atrophy) (Lin et al., 2001) . Some of these mice died of a wasting syndrome (loss of weight) that involved suppression of hematopoiesis without extensive tumor cell invasion of the spleen and marrow as observed in a typical leukemia. Our preliminary findings indicate these K562 cell clones have enhanced expression of NGAL (neutrophil gelatinaseassociated lipocalin) (Hui Lin, Tong Sun, and R Arlinghaus, unpublished), which is the human counterpart of 24p3 (Kjeldsen et al., 1993; Yousefi and Simon 2002) . Of interest, NGAL is present in granules of neutrophils, as is LAI (Skold et al., 1999; Kjeldsen et al., 2000) . It is of interest to determine whether NGAL is responsible for the suppression of hematopoiesis in spleen and marrow by clones of K562 cells that we observed in these previous experiments (Lin et al., 2001 ).
Materials and methods
Cell lines, plasmid, lentivirus vectors
The clone 3 line of 32D cells expressing P210 BCR-ABL (b3/ a2) and other mouse hematopoietic cell lines (FL5. 12, FDC-P1, BaF3) were maintained as described (McCubrey et al., 1993) . 24p3 plasmid was provided by Michael Green (University of Mass.). Both sense and antisense 24p3 were inserted into a lenitivirus transduction plasmid, which contains a bi-cistronic coding structure using an internal ribosomsal entry site (IRES) followed by the GFP gene (Ling et al., 2003) . Transcription is driven by an EF-1a promoter (Ling et al., 2003) . Lentiviruses encoding 24p3 siRNA were constructed as described (Ling et al., 2003; Wiznerowicz and Trono, 2003) . Briefly, the siRNA is formulated as a small hairpin (sh) RNA driven by H1 promoter; the construct has EF-1a promoter to drive the GFP. The sequences of these constructs are: #4, GGCAGCTTTACGATGTACA-TTCAAGAGA-TGTACATC GTAAAGCTGCC-TTTTTTCCAAT (sense-loop-antisensetermination region); #11, CATTTGTTCCAAGCTCCAG-TTCAAGAGA-CTGGAGCTTGGA ACAAATG-TTTTTTCC AAT.
PCR and Western blotting
Total RNA was extracted and cDNA was prepared as described (Guo et al., 2002) . 24p3 PCR amplimers were detected by RT-PCR using two oligonucleotide primers: forward primer: AGCCAGACTTCCGGAGCGATC; reverse primer: ACTTGGCAAAGCGGGTGAAACG. For real-time RT-PCR: probe: 24p3 p144 (DFAM)CCT GGC AGG CAA TGC GGT CC(DTAM); forward primer: 24p3 FW123 GGG CAG GTG GTA CGT TGT G; reverse primer:24p3 RV190 CGT AAA GCT GCC TTC TGT TTT TTT. Western blotting was performed as described (Xie et al., 2002) . CM was prepared as described (Devireddy et al., 2001) . Apoptosis assays were performed by flow cytometry to detect and quantitate by Annexin V reactivity.
Mouse leukemia models
The NOD/scid model was used as described (Lin et al., 2001) . 10e6 BCR-ABL þ 32D cells were injected i.v., either vector transduced/GFP) or antisense 24p3/GFP. The C3H/HeJ mouse model was used as described (Matulonis et al., 1995) ; 1.0 Â 10e6 cells were injected i.v. Tissues were analysed in our veterinary core facility. TUNEL staining was performed in the Division of Pathology core facility.
